Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT05950724
EARLY_PHASE1
RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
Sponsor: Northwestern University
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess whether TNFa antibody use before lung transplant can prevent kidney injury after lung transplant.
Official title: RENAL: Randomized Clinical Trial of TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2023-09-17
Completion Date
2027-12
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
DRUG
Etanercept Injection [Enbrel]
25 mg subcutaneous injection
Locations (1)
Northwestern University
Chicago, Illinois, United States